Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dysregulation of histone deacetylases in carcinogenesis and tumor progression: a possible link to apoptosis and autophagy
Srimanta Patra, Debasna Pritimanjari Panigrahi, Prakash Priyadarshi Praharaj, et al.
Cellular and Molecular Life Sciences (2019) Vol. 76, Iss. 17, pp. 3263-3282
Closed Access | Times Cited: 39

Showing 1-25 of 39 citing articles:

Autophagy-modulating phytochemicals in cancer therapeutics: Current evidences and future perspectives
Srimanta Patra, Soumya Ranjan Mishra, Bishnu Prasad Behera, et al.
Seminars in Cancer Biology (2020) Vol. 80, pp. 205-217
Closed Access | Times Cited: 106
Exploring the role of histone deacetylase and histone deacetylase inhibitors in the context of multiple myeloma: mechanisms, therapeutic implications, and future perspectives
Jingjing Pu, Ting Liu, Xuzhen Wang, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 11
FGF21 facilitates autophagy in prostate cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway
Han Dai, Wenjing Hu, Lianying Zhang, et al.
Cell Death and Disease (2021) Vol. 12, Iss. 4
Open Access | Times Cited: 48
Characterization of Histone Deacetylase Mechanisms in Cancer Development
Rihan Hai, Liuer He, Guang Shu, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 47
Targeting Histone Deacetylases: Opportunities for Cancer Treatment and Chemoprevention
Dušan Ružić, Nemanja Djoković, Tatjana Srdić‐Rajić, et al.
Pharmaceutics (2022) Vol. 14, Iss. 1, pp. 209-209
Open Access | Times Cited: 37
Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention
Srimanta Patra, Prakash Priyadarshi Praharaj, Amruta Singh, et al.
Drug Discovery Today (2023) Vol. 28, Iss. 9, pp. 103692-103692
Closed Access | Times Cited: 18
Vorinostat in autophagic cell death: A critical insight into autophagy-mediated, -associated and -dependent cell death for cancer prevention
Srimanta Patra, Prakash Priyadarshi Praharaj, Daniel J. Klionsky, et al.
Drug Discovery Today (2021) Vol. 27, Iss. 1, pp. 269-279
Open Access | Times Cited: 39
Natural Bioactive Compounds Targeting Histone Deacetylases in Human Cancers: Recent Updates
Abdelhakim Bouyahya, Naoufal El Hachlafi, Tarik Aanniz, et al.
Molecules (2022) Vol. 27, Iss. 8, pp. 2568-2568
Open Access | Times Cited: 23
Liquiritigenin exerts the anti-cancer role in oral cancer via inducing autophagy-related apoptosis through PI3K/AKT/mTOR pathway inhibition in vitro and in vivo
Yingchen Ji, Weiwei Hu, Yan Jin, et al.
Bioengineered (2021) Vol. 12, Iss. 1, pp. 6070-6082
Open Access | Times Cited: 30
Structural characterization, antioxidant activity, and mechanism of polysaccharides isolated from Dictyophora rubrovalvata stipet
Tengda Li, Xiaolei Cheng, Kaisheng Bao, et al.
International Journal of Biological Macromolecules (2025) Vol. 306, pp. 141576-141576
Closed Access
Histone Deacetylase Inhibitors in the Management of Advanced Cancers
Nicolas Sayegh, Valerie Etzrodt
JCO Precision Oncology (2025), Iss. 9
Closed Access
Roles of Histone Deacetylases in Acute Myeloid Leukemia With Fusion Proteins
Juan Zhang, Xuefeng Gao, Li Yu
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 25
Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways
Srimanta Patra, Prakash Priyadarshi Praharaj, Debasna Pritimanjari Panigrahi, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 9, pp. 7209-7228
Closed Access | Times Cited: 23
Delayed Impact of 2-Oxoadipate Dehydrogenase Inhibition on the Rat Brain Metabolism Is Linked to Protein Glutarylation
Alexandra Boyko, Irina S. Karlina, Lev Zavileyskiy, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 13
A proteasome-dependent inhibition of SIRT-1 by the resveratrol analogue 4,4′-dihydroxy-trans-stilbene
Vittoria Livraghi, L Mazza, Federica Chiappori, et al.
Journal of Traditional and Complementary Medicine (2024) Vol. 14, Iss. 5, pp. 534-543
Open Access | Times Cited: 2
Possible Mechanisms for Maintenance and Regression of Corpus Luteum Through the Ubiquitin-Proteasome and Autophagy System Regulated by Transcriptional Factors
Aamir Salam Teeli, Paweł Leszczyński, Narayanan Krishnaswamy, et al.
Frontiers in Endocrinology (2019) Vol. 10
Open Access | Times Cited: 19
The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells
Laura Urwanisch, Michael S. Unger, Helene Sieberer, et al.
Cancers (2023) Vol. 15, Iss. 4, pp. 1039-1039
Open Access | Times Cited: 6
Intricate role of mitochondrial calcium signalling in mitochondrial quality control for regulation of cancer cell fate
Srimanta Patra, Kewal Kumar Mahapatra, Prakash Priyadarshi Praharaj, et al.
Mitochondrion (2021) Vol. 57, pp. 230-240
Closed Access | Times Cited: 14
MicroRNA-326 impairs chemotherapy resistance in non small cell lung cancer by suppressing histone deacetylase SIRT1-mediated HIF1α and elevating VEGFA
Jinying Wei, Guangping Meng, Jing Wu, et al.
Bioengineered (2021) Vol. 13, Iss. 3, pp. 5685-5699
Open Access | Times Cited: 14
Dysregulation of Histone Deacetylases Inhibits Trophoblast Growth during Early Placental Development Partially through TFEB-Dependent Autophagy-Lysosomal Pathway
Peixin Wang, Chenqiong Zhao, Hanjing Zhou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 11899-11899
Open Access | Times Cited: 5
Molecular Inverse Comorbidity between Alzheimer’s Disease and Lung Cancer: New Insights from Matrix Factorization
Alessandro Greco, Jon Sánchez-Valle, Véra Pancaldi, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 13, pp. 3114-3114
Open Access | Times Cited: 14
Sodium cantharidate promotes autophagy in breast cancer cells by inhibiting the PI3K–Akt–mTOR signaling pathway
Jinlong Pang, Lian-Song Xu, Qian Zhao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 8
Long non-coding RNA H19 enhances the pro-apoptotic activity of ITF2357 (a histone deacetylase inhibitor) in colorectal cancer cells
Chiara Zichittella, Marco Loria, Adriana Celesia, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 4
Fisetin reduces the resistance of MOLT-4 and K562 cells to TRAIL-induced apoptosis through upregulation of TRAIL receptors
Lei Liu, Shaik Althaf Hussain, Xiaoyan Hu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 12, pp. 9689-9700
Closed Access | Times Cited: 1
Acetylation of Histone H3 in Cancer Progression and Prognosis
Paulina Miziak, Marzena Baran, Lidia Borkiewicz, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10982-10982
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top